SCHEMBL25820620

SCHEMBL25820620

N#Cc1ccc2nccc(Nc3ccc(F)c(C(=O)Nc4cccc(Nc5ccccc5)c4)c3)c2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 5/20 0.49
DNMT3A Q9Y6K1 4/20 0.49
GRM5 P41594 1/20 0.48
MAPKAPK2 P49137 2/20 0.47
KMT2A Q03164 3/20 0.45
MAPT P10636 2/20 0.45
MEN1 O00255 2/20 0.45
GAA P10253 1/20 0.45
GAK O14976 1/20 0.44
RIPK2 O43353 1/20 0.44
COQ8A Q8NI60 1/20 0.44
NLK Q9UBE8 1/20 0.44
DNMT3L Q9UJW3 2/20 0.44
EGFR P00533 2/20 0.44
CCNC P24863 1/20 0.43
CDK8 P49336 1/20 0.43
HTT P42858 1/20 0.43
MAP3K8 P41279 1/20 0.43
KDM4E B2RXH2 1/20 0.43
USP2 O75604 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25826554 0.95 MAPT (0.49) DNMT1DNMT3AGRM5MAPKAPK2KMT2A
SCHEMBL25820605 0.89 BRAF (0.51) DNMT1DNMT3AMAPKAPK2KMT2AMAPT
SCHEMBL24006016 0.89 KMT2A (0.54) DNMT1DNMT3AGRM5MAPKAPK2KMT2A
SCHEMBL25820661 0.88 DNMT1 (0.53) DNMT1DNMT3AKMT2AMAPTMEN1
SCHEMBL24003789 0.88 DNMT1 (0.59) DNMT1DNMT3AMAPKAPK2KMT2AMAPT
SCHEMBL24003760 0.88 KMT2A (0.51) DNMT1DNMT3AMAPKAPK2KMT2AMAPT
SCHEMBL25820621 0.88 DNMT1 (0.47) DNMT1DNMT3AMAPKAPK2KMT2AMAPT
SCHEMBL25820616 0.87 DNMT1 (0.51) DNMT1DNMT3AMAPKAPK2KMT2AMAPT
SCHEMBL25820633 0.87 DNMT1 (0.61) DNMT1DNMT3AMAPKAPK2GAKRIPK2
SCHEMBL24010972 0.86 DNMT1 (0.64) DNMT1DNMT3AMAPKAPK2KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219927-A1 AKT3 MODULATORS AKT3, AKT2, PIK3CA DNMT1 4335/4885DNMT3A 4603/4885GRM5 2844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.